Explanipedia

Neutrophil‐to‐lymphocyte ratio for risk stratification in acute myocarditis across the left ventricular ejection fraction spectrum Open

Cristina Madaudo, Amitai Segev, Emanuele Bobbio, Chiara Baggio, Jonathan Schütze , et al. · 2025

Aims Acute myocarditis (AM) is a heterogeneous clinical condition. Several classification models have been proposed to predict adverse clinical outcomes, but risk stratification remains challenging, particularly for patients presenting wit…

Advancing Heart Failure Care: Breakthroughs and Emerging Strategies Open

Andrea Tedeschi, Federico Barocelli, Luigi Gerra, F Breviario, Matteo Palazzini , et al. · 2025

Heart failure represents a complex clinical syndrome characterized by progressive ventricular dysfunction, systemic congestion, and high mortality despite significant advances in pharmacological and device-based therapy. This review explor…

2025 ESC Guidelines for the management of myocarditis and pericarditis Open

Jeanette Schulz‐Menger, Valentino Collini, Jan Gröschel, Yehuda Adler, Antonio Brucato , et al. · 2025

Parvovirus B19‐associated myocarditis in children: A systematic review of clinical features, management and outcomes Open

Giacomo Veronese, Giada Colombo, Andrea Garascia, Rachele Adorisio, Ezio Bonanomi , et al. · 2025

Background Parvovirus B19 (PVB19) has emerged as a relevant etiologic agent of paediatric myocarditis, particularly during recent epidemiological surges in Europe and the United States. Despite increasing recognition, current knowledge rem…

11 - The influence of a dedicated environment and postoperative care on urinary diversions in neurogenic lower urinary tract dysfunctions (nlutds) Open

Paolo Geretto, Alberto Manassero, Enrico Ammirati, Marco Falcone, Marco Agnello , et al. · 2025

44 - Add-on treatment with a Nuciferin–protopin solution For BPS/IC Open

Enrico Ammirati, Paolo Geretto, Carla Crestani, Mara Riccardi, Stefania Spinapolice , et al. · 2025

2 - Pudendal nerve block, pulsed-radiofrequency and sacral neuromodulation: Description of a diagnostic–therapeutic pathway for chronic pelvic pain associated with pudendal neuralgia Open

Marco Agnello, Mario Vottero, Enrico Ammirati, Stefania Chierchia, Alberto Manassero , et al. · 2025

Left ventricular decompression in paediatric veno‐arterial extracorporeal life support: Reviewing the evidence Open

Giacomo Veronese, Paolo Meani, Domenico Sirico, Giovanni Di Salvo, Enrico Ammirati , et al. · 2025

Veno‐arterial extracorporeal life support (VA ECLS) is crucial for neonatal and paediatric patients with severe circulatory collapse but may cause left ventricular (LV) overload, affecting myocardial recovery and causing complications. Evi…

Stroke in Heart Failure With Reduced Ejection Fraction Open

Guglielmo Gallone, Federica Savoca, D Miccoli, Michael Böhm, Gaetano Maria De Ferrari , et al. · 2025

Management of patients with myocarditis and arrhythmogenic phenotype Open

Enrico Ammirati, Matteo Palazzini, Piero Gentile, Nicolina Conti, Paola Sormani , et al. · 2025

Acute myocarditis (AM) is an inflammatory condition of the myocardium that may lead to severe complications, including acute heart failure and life-threatening ventricular arrhythmias (VAs). In-hospital VAs are estimated to affect 2.5% of …

Acute myocarditis: 2024 state of the art Open

Enrico Ammirati, Iside Cartella, Marisa Varrenti, Adelina Selimi, Paola Sormani , et al. · 2025

Acute myocarditis (AM) is an inflammatory injury of the myocardium secondary to infections, systemic autoimmune disorders, medications, or toxic agents. The patient’s genetic underground is a likely concurrent aetiology/contributory mechan…

Elevated Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Acute Myocarditis Open

Antonio Cannatà, Amitai Segev, Cristina Madaudo, Emanuele Bobbio, Chiara Baggio , et al. · 2025

Tailored therapies for patients affected by systemic sclerosis with primary heart involvement: The role of rituximab Open

Daniela Tomasoni, Enrico Ammirati, Marco Metra · 2024

Cardiovascular and brain health determinants: the case of white matter hyperintensities Open

Enrico Ammirati, Suzahn Erin Ebert, Francesco Moroni · 2024

A fearsome evolution of presumed cardiac sarcoidosis: The sarcoid-lymphoma syndrome Open

Paola Sormani, Enrico Ammirati, Cristina Giannattasio, Andrea Garascia, Patrizia Pedrotti · 2024

Charting the Unseen: How Non-Invasive Imaging Could Redefine Cardiovascular Prevention Open

Giancarlo Trimarchi, Fausto Pizzino, Umberto Paradossi, Ignazio Alessio Gueli, Matteo Palazzini , et al. · 2024

Cardiovascular diseases (CVDs) remain a major global health challenge, leading to significant morbidity and mortality while straining healthcare systems. Despite progress in medical treatments for CVDs, their increasing prevalence calls fo…

6 - Bladder instillations of Adelmidrol+ Sodium Hyaluronate in patients with symptomatic actinic cystitis: Efficacy of the treatment Open

Francesco Maria Bracco, Enrico Ammirati, Paolo Geretto, Marco Falcone, Alberto Manassero , et al. · 2024

46 - Changes of uroflowmetry parameters in women with recurrent urinary tract infections: A multicenter comparative Italian study Open

Emanuele Rubilotta, Matteo Balzarro, Luca Roggero, Enrico Ammirati, Stefania Chierchia , et al. · 2024

57 - Urodynamic versus video-urodynamic evaluation in neurogenic bladder: Which is the best diagnostic tool? Open

Paolo Geretto, Enrico Ammirati, Alberto Manassero, N. Deanesi, Anca Georgiana Mesterca , et al. · 2024

42 - Intravesical treatment with Hyaluronic Acid and Chondroitin Sulphate in patients with recurrent urinary tract infections: Which protocol of instillations to use? Open

Marilena Gubbiotti, Alessandro Giammò, Stefano Rosadi, Enrico Ammirati, Elisabetta Costantini , et al. · 2024

63 - Battery depletion of implanted pulse generator in Sacral Neuromodulation: How do we notice it? And what could we do to ensure the continuity of care? Open

Marco Agnello, Mario Vottero, Enrico Ammirati, Paolo Geretto, Paola Bertapelle · 2024

Heart Failure Management through Telehealth: Expanding Care and Connecting Hearts Open

Andrea Tedeschi, Matteo Palazzini, Giancarlo Trimarchi, Nicolina Conti, Francesco Di Spigno , et al. · 2024

Heart failure (HF) is a leading cause of morbidity worldwide, imposing a significant burden on deaths, hospitalizations, and health costs. Anticipating patients’ deterioration is a cornerstone of HF treatment: preventing congestion and end…

SARS–COV2 INFECTIONS IN HEART TRANSPLANT RECIPIENTS: VACCINES STILL ARE OUR GREATEST WEAPON Open

Andrea Tedeschi, Enrico Ammirati, Andrea Garascia, Matteo Palazzini, Gabriella Masciocco , et al. · 2024

Long–term clinical follow–ups are needed to assess the effectiveness of vaccine and booster doses against severe acute respiratory syndrome coronavirus 2 (SARS–CoV2) infection for heart transplant (HT) recipients, particularly in an epidem…

SARS-CoV2 infections in heart transplant recipients: Vaccines still are our greatest weapon Open

Andrea Tedeschi, Piero Gentile, Matteo Palazzini, Gabriella Masciocco, Filippo Leidi , et al. · 2024

Cardiac Involvement in Patients With Multisystem Inflammatory Syndrome in Adults Open

Giulia La Vecchia, Marco Giuseppe Del Buono, Aldo Bonaventura, Alessandra Vecchié, Francesco Moroni , et al. · 2024

Multisystemic inflammatory syndrome in adults is a hyperinflammatory condition following (within 4-12 weeks) SARS-CoV-2 infection. Here, the dysregulation of the immune system leads to a multiorgan involvement often affecting the heart. Ca…

Pirfenidone As Potential Therapeutic Intervention for Coronavirus Disease-19 (COVID-19) Open

Bei Wang, Jing Chen, Chenze Li, Lingli Dong, Dao Wen Wang , et al. · 2024

Background: Coronavirus disease 2019 (COVID-19) is a pandemic with no specific drugs and high fatality. The most urgent need is to find effective treatments. We sought to determine whether pirfenidone treatment might reduce the death risk …

Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes Open

Beatrice Musumeci, Giacomo Tini, Elena Biagini, Marco Merlo, Chiara Calore , et al. · 2024

Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population Open

Edoardo Bertero, Chiara Chiti, Maria Alessandra Schiavo, Giacomo Tini, P. Costa , et al. · 2023

Aims In the EXPLORER‐HCM trial, mavacamten reduced left ventricular outflow tract obstruction (LVOTO) and improved functional capacity of symptomatic hypertrophic obstructive cardiomyopathy (HOCM) patients. We sought to define the potentia…

Global Burden of Cardiovascular Diseases and Risks, 1990-2022 Open

George A. Mensah, Valentı́n Fuster, Christopher J L Murray, Gregory A. Roth, George A. Mensah , et al. · 2023

Recent highlights on myocarditis and cardiomyopathies from the International Journal of Cardiology and International Journal of Cardiology: Heart & Vasculature Open

Nicolina Conti, Enrico Ammirati, Andrea Tedeschi, Dobromir Dobrev · 2023

Enrico Ammirati YOU? Author Swipe